Home > A. Molecular pathology > Targeted therapy > HSP90 inhibitors
HSP90 inhibitors
Monday 2 May 2016
hsp90 inhibitors
| WP |
An Hsp90 inhibitor is a substance that inhibits that activity of the Hsp90 heat shock protein. Since Hsp90 stabilizes a variety of proteins required for survival of cancer cells, these substances may have therapeutic benefit in the treatment of various types of malignancies.
Furthermore a number of Hsp90 inhibitors are currently undergoing clinical trials for a variety of cancers.
Hsp90 inhibitors include the natural products geldanamycin and radicicol as well as semisynthetic derivatives 17-N-Allylamino-17-demethoxygeldanamycin (17AAG).
Examples
gaminitrib
NVP-AUY922
See also
HSP90
targeted therapy
News
